Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - flugestone acetate - misc. intra vaginal/uterine prep/device - flugestone acetate steroid-progestin active 20.0 mg/sp - endocrine system - goat | sheep | billy | buck | capra hircus | doe | ewe | hogget | kid | lamb | ovine | ram | weaner | wether - induction of ovulation | synchronisation of ovulation

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pestech australia pty. ltd. - piperonyl butoxide; pyrethrins; liquid hydrocarbon - aerosol - piperonyl butoxide benzodioxole active 24.0 g/l; pyrethrins pyrethroid-pyrethrin active 4.0 g/l; liquid hydrocarbon solvent other 813.0 g/l - insecticide - outdoor area - general | shed,factory,warehouse or other building - cockroach | flour moth | fly | grain moth | midge | mite | mosquito | spider | vinegar fly | weevil | adult mosquitoes | large cockroach | small cockroach | spider mite

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: glycerol; water for injections; sodium hydroxide; dilute hydrochloric acid - idarubicin ebewe is indicated for use in acute myelogenous leukaemia (aml) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. idarubicin ebewe may be used in combination chemotherapy regimens involving other cytotoxic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: glycerol; dilute hydrochloric acid; water for injections; sodium hydroxide - idarubicin ebewe is indicated for use in acute myelogenous leukaemia (aml) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. idarubicin ebewe may be used in combination chemotherapy regimens involving other cytotoxic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; dilute hydrochloric acid; glycerol - idarubicin ebewe is indicated for use in acute myelogenous leukaemia (aml) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. idarubicin ebewe may be used in combination chemotherapy regimens involving other cytotoxic agents.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - oxycodone hydrochloride; paracetamol - tablets - oxycodone hydrochloride 10 mg; paracetamol 325 mg - paracetamol - paracetamol - for the relief of moderate to moderately severe pain.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - oxycodone hydrochloride; paracetamol - tablets - paracetamol 325 mg; oxycodone hydrochloride 5 mg - paracetamol, combinations with psycholeptics - paracetamol, combinations with psycholeptics - for the relief of moderate to moderately severe pain.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kck pharmaceutical industries sdn. bhd. - risperidone -

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride 2 mg - tiagabine hydrochloride tablets are indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. tiagabine hydrochloride tablets are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of tiagabine hydrochloride have not been evaluated in human studies.